484 related articles for article (PubMed ID: 16432602)
1. Antimony-induced cerebellar ataxia.
Khalil EA; Ahmed AE; Musa AM; Hussein MH
Saudi Med J; 2006 Jan; 27(1):90-2. PubMed ID: 16432602
[TBL] [Abstract][Full Text] [Related]
2. Cumulative cardiac toxicity of sodium stibogluconate and amphotericin B in treatment of kala-azar.
Maheshwari A; Seth A; Kaur S; Aneja S; Rath B; Basu S; Patel R; Dutta AK
Pediatr Infect Dis J; 2011 Feb; 30(2):180-1. PubMed ID: 20823781
[TBL] [Abstract][Full Text] [Related]
3. A comparison of liposomal amphotericin B with sodium stibogluconate for the treatment of visceral leishmaniasis in pregnancy in Sudan.
Mueller M; Balasegaram M; Koummuki Y; Ritmeijer K; Santana MR; Davidson R
J Antimicrob Chemother; 2006 Oct; 58(4):811-5. PubMed ID: 16916865
[TBL] [Abstract][Full Text] [Related]
4. Leishmania donovani: an in vitro study of antimony-resistant amphotericin B-sensitive isolates.
Sharief AH; Gasim Khalil EA; Theander TG; Kharazmi A; Omer SA; Ibrahim ME
Exp Parasitol; 2006 Dec; 114(4):247-52. PubMed ID: 16716301
[TBL] [Abstract][Full Text] [Related]
5. Visceral leishmaniasis: a rare cause of post-transplant fever and pancytopenia.
Rajaram KG; Sud K; Kohli HS; Gupta KL; Sakhuja V
J Assoc Physicians India; 2002 Jul; 50():979-80. PubMed ID: 12126362
[TBL] [Abstract][Full Text] [Related]
6. [A case of antimony resistant kala-azar cured with amphotericin B].
Chen SB; Yang CM; Zhang CJ
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Jun; 25(3):inside front page. PubMed ID: 18038767
[No Abstract] [Full Text] [Related]
7. Sodium stibogluconate-sensitive visceral leishmaniasis in the non-endemic hilly region of Uttarakhand, India.
Verma SK; Ahmad S; Shirazi N; Kusum A; Kaushik RM; Barthwal SP
Trans R Soc Trop Med Hyg; 2007 Jul; 101(7):730-2. PubMed ID: 17382981
[TBL] [Abstract][Full Text] [Related]
8. Magnitude of unresponsiveness to sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar.
Das VN; Ranjan A; Bimal S; Siddique NA; Pandey K; Kumar N; Verma N; Singh VP; Sinha PK; Bhattacharya SK
Natl Med J India; 2005; 18(3):131-3. PubMed ID: 16130613
[TBL] [Abstract][Full Text] [Related]
9. Acute erythroid toxicity in visceral leishmaniasis: a rare complication of antimonial therapy.
Sharma S; Malhan P; Pujani M; Rath B
Indian J Pathol Microbiol; 2008; 51(4):546-7. PubMed ID: 19008592
[TBL] [Abstract][Full Text] [Related]
10. Varicella zoster virus meningitis complicating sodium stibogluconate treatment for cutaneous leishmaniasis.
Hartzell JD; Aronson NE; Nagaraja S; Whitman T; Hawkes CA; Wortmann G
Am J Trop Med Hyg; 2006 Apr; 74(4):591-2. PubMed ID: 16606989
[TBL] [Abstract][Full Text] [Related]
11. Activities of hexadecylphosphocholine (miltefosine), AmBisome, and sodium stibogluconate (Pentostam) against Leishmania donovani in immunodeficient scid mice.
Escobar P; Yardley V; Croft SL
Antimicrob Agents Chemother; 2001 Jun; 45(6):1872-5. PubMed ID: 11353640
[TBL] [Abstract][Full Text] [Related]
12. Holiday souvenirs from the Mediterranean: three instructive cases of visceral leishmaniasis.
Buonomano R; Brinkmann F; Leupin N; Boscacci R; Zimmermann A; Müller N; Fux CA
Scand J Infect Dis; 2009; 41(10):777-81. PubMed ID: 19593691
[TBL] [Abstract][Full Text] [Related]
13. Drug regimens for visceral leishmaniasis in Mediterranean countries.
Gradoni L; Soteriadou K; Louzir H; Dakkak A; Toz SO; Jaffe C; Dedet JP; Campino L; Cañavate C; Dujardin JC
Trop Med Int Health; 2008 Oct; 13(10):1272-6. PubMed ID: 18764817
[TBL] [Abstract][Full Text] [Related]
14. Leishmania donovani: genetic diversity of isolates from Sudan characterized by PCR-based RAPD.
Hamad SH; Khalil EA; Musa AM; Ibrahim ME; Younis BM; Elfaki ME; El-Hassan AM;
Exp Parasitol; 2010 Aug; 125(4):389-93. PubMed ID: 20346944
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of visceral leishmaniasis in children].
Minodier P; Noël G; Blanc P; Uters M; Retornaz K; Garnier JM
Med Trop (Mars); 2007 Feb; 67(1):73-8. PubMed ID: 17506279
[TBL] [Abstract][Full Text] [Related]
16. Leishmania species, drug unresponsiveness and visceral leishmaniasis in Bihar, India.
Thakur CP; Dedet JP; Narain S; Pratlong F
Trans R Soc Trop Med Hyg; 2001; 95(2):187-9. PubMed ID: 11355558
[TBL] [Abstract][Full Text] [Related]
17. [Visceral leishmaniasis refractory to treatment: the efficacy of amphotericin B].
Pérez Brea A; Ruiz Moreno M; Leal Orozco A; Escorihuela Esteban R; Otero Fraguas M
An Esp Pediatr; 1996 Feb; 44(2):161-3. PubMed ID: 8830578
[No Abstract] [Full Text] [Related]
18. Sodium stibogluconate.
Shrestha NK
Clin Infect Dis; 2006 Nov; 43(10):1371-2. PubMed ID: 17051510
[No Abstract] [Full Text] [Related]
19. Epidemiological, clinical & pharmacological study of antimony-resistant visceral leishmaniasis in Bihar, India.
Thakur CP; Narayan S; Ranjan A
Indian J Med Res; 2004 Sep; 120(3):166-72. PubMed ID: 15489554
[TBL] [Abstract][Full Text] [Related]
20. Antimony-resistant Leishmania donovaniin eastern Sudan: incidence and in vitro correlation.
Abdo MG; Elamin WM; Khalil EA; Mukhtar MM
East Mediterr Health J; 2003 Jul; 9(4):837-43. PubMed ID: 15748080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]